Amiodarone belongs to the Heart & Blood Pressure category of medicines and is used to treat serious cardiac rhythm disturbances. It is available in pill form in strengths of 100 mg and 200 mg. In Hong Kong, amiodarone is a prescription-only medication and is regulated by the Department of Health under the Pharmacy and Poisons Ordinance.
Amiodarone is classified as a Class III anti-arrhythmic agent. It prolongs the cardiac action potential by blocking potassium channels, which lengthens the refractory period of myocardial tissue. This effect slows electrical conduction and helps restore a regular heart rhythm. The drug also modestly blocks sodium, calcium, and β-adrenergic receptors, contributing to its broad anti-arrhythmic activity. Onset of action typically occurs within a few hours after oral administration, with peak plasma concentrations reached in about 3-7 days. The long elimination half-life (several weeks) reflects extensive tissue binding, which is why steady-state levels develop gradually.
Amiodarone is approved in Hong Kong for the management of:
These indications are based on extensive clinical studies and the drug’s ability to maintain sinus rhythm in patients at high risk of arrhythmic relapse.
Special populations such as the elderly may experience heightened sensitivity to side effects and often require closer monitoring.
Regular follow-up is essential due to amiodarone’s extensive side-effect profile:
Patients should contact their healthcare provider promptly if they experience new shortness of breath, persistent cough, visual changes, or unexplained fatigue.
This article provides educational information about amiodarone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
A rash, especially if accompanied by itching or swelling, may indicate a photosensitivity reaction or an allergic response. Stop sun exposure, use gentle skin moisturizers, and contact your healthcare provider for evaluation; a dosage adjustment or alternative therapy may be necessary.
Amiodarone can be combined with beta-blockers, but the combination may increase the risk of bradycardia or AV-block. Your doctor will monitor heart rate and may adjust the doses of one or both agents.
Because amiodarone has a very long half-life, steady-state concentrations usually develop after several weeks of consistent dosing. This delayed buildup contributes to both its prolonged therapeutic effect and the potential for late-onset side effects.
Older adults are more susceptible to certain adverse effects, such as pulmonary toxicity and liver enzyme elevation. Dose initiation at the lower 100 mg strength and close monitoring of organ function are common strategies to improve safety in this population.
The drug deposits in the skin and may lead to a blue-gray discoloration, especially on areas exposed to sunlight. The change is cosmetic and usually reverses after discontinuation, though it may persist for months.
Hypothyroidism may present with fatigue, weight gain, and cold intolerance, while hyperthyroidism may cause anxiety, heat intolerance, weight loss, and rapid heart rate. Regular thyroid function testing helps detect these changes early.
Amiodarone is a prescription medication, so you should carry the original prescription label and a copy of the prescription when traveling. No special security restrictions exist beyond standard customs requirements for prescription drugs.
Supplements containing iodine or high-dose vitamin K may interact with amiodarone’s effects on thyroid function. Discuss all supplements with your pharmacist or physician before starting them.
Amiodarone is highly effective for a broad range of arrhythmias but carries a higher risk of organ-specific toxicity compared with newer agents such as dronedarone or sotalol. Choice of therapy depends on the specific arrhythmia, patient comorbidities, and risk-benefit assessment by the clinician.
If you experience dizziness, visual disturbances, or significant heart-rate changes while on amiodarone, you should avoid operating motor vehicles until your symptoms are evaluated and controlled.
